SORT BY Relevancy
What are the latest developments in the world of GMOs? From GMO labeling laws, global outrage, corporate product pipelines, to the debacle over the Seralini study on human health risks, we will examine new aspects to the biotech business and their implications for the health and safety of consumers worldwide. We may know where we have been and we may know where we are in the midst of the genetically modified debate, but can we see where we are going?
The CMO of a biotech is like no other job in the world. The CMO is not only responsible for delivering on clinical trials, but also is a key player in the company's fundraising efforts.
From the Chief Medical Officer Summit, please join co-chairs Dr. Greg Fiore, CMO of the The Medicines Company and Dr. Steven Zelenkofske, CMO of Regado together with opening presenter Dr. Tyler Martin, CMO & Founder of Great Plains Biotechnology, to discuss the role of the CMO and how to best manage it.
What should a CMO be focused on? Functioning with restrictive capital Supporting a CEO who does not have experience in the therapeutic area you are in charge of The great balancing act
Linda Peacock is currently an Infusion Account Manager for a global biotech company. Linda’s role is educating healthcare professionals in hospitals, infusion centers, and offices in a large territory in the Northeast.
An accomplished health management professional with extensive clinical expertise within the hospital, specialty pharmacy, pharmaceutical and biotech industries, Linda's career spans several decades and includes 17 years at Albany Medical College and nine years as an Assistant Executive Director of a regional hemophilia center. She has been very successful in many roles in the pharmaceutical industry, including with her current company.
Linda received her RN in 1992 after many years as a nurse’s aide and LPN. In 1994, she received her BSN at Regents College (now known as Excelsior College). In 1999, she was awarded an MBA by the State University New York at Albany.
Donald Jones, Chief Digital Officer, Scripps Translational Science Institute talks with host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer on what's happening with digital in drug development. Don discusses his thoughts on the evolution of new products with digital and the “digitazation” of tools for clinical trials. He also shares his thoughts on the biggest disruptors in pharma.
Don and Craig will be featured in an interview as well at DPharm: Disruptive Innovations to Advance Clinical Trials on September 11, 2014 in Boston.
Head of Clinical Innovation, R&D
Chief Digital Officer
Scripps Translational Science Institute
Founder & Chairman, Wireless Life Sciences Alliance
The Conference Forum
in Self Help
Satya Kalra is a self-transformation, empowerment, and happiness coach, spiritual guide, international speaker, and bestselling author of several books including, “My Questions & God’s Answers,” “Yoga Beyond Asana” and her newest release, “Ultimate Happiness Health & Chakras: A Blissful Journey through 7 Wonders of the Soul.” She is also a founder and president of the non-profit organization, “Path to Anandam” to help people explore their eternal happiness and peace within. She is popularly known for the Anandam Lifestyle (Blissful Living).
Prior to founding the Path to Anandam, Satya Kalra had been through many facets in her life. She has been a veteran in the biotech industry for 35 years serving as a visionary, entrepreneur, scientist, founder, CEO, president and chairperson. For more than 20 years, Satya has been practicing and promoting awareness of blissful living through applications of the timeless wisdom of the Bhagavad Gita and spirituality in daily life.
Get the OFF TO WORK CD by Sister Jenna. Like America Meditating on Facebook, visit our website and follow us on Twitter.
COSMIC VISION NEWS – 15AUG - SHOW SUMMARY
BEESWAX PRODUCTS: http://purebeeworks.com DISCOUNT CODE (10%) FOR PURCHASES: GAO12
1. ISRAEL DEATH RAY INTRODUCED ON GAZA. ( 01:09 MARK )
2. NATO HYPOCRISY: WESTERN COUNTRIES GIVE UKRAINE MILITARY AID, WHILE HUMANITARIAN AID FROM RUSSIA IS ‘ILLEGAL’.
3. IRAQ: PM AL-MALIKI RESIGNS; LEADERSHIP CHANGE UNDERWAY.
4. ROMANIA: OLIGARCH ARRESTED; COUNTRY MOVING TOWARDS ROOTING OUT CORRUPTION.
5. ‘DE-DOLLARIZATION’ CONTINUES: MORE COUNTRIES MOVING TOWARDS DUMPING US PETRODOLLAR.
6. CONSOLIDATION OF LAWSUITS AGAINST BANKS GUILTY OF GOLD FIX MANIPULATION.
7. TRANSFORMATION IN FERGUSON: NEW POLICE CONTROL IN COMMUNITY EXCHANGES WEAPONS FOR HUGS AND KISSES.
8. CHILE: UFO’S POST NO HARM TO AIRCRAFT: HIGH-LEVEL MILITARY/SCIENTIFIC CONCLUSION.
9. TECH: 3D PRINTING MOVES TO WOOD AND METAL; AN EVOLUTION IN SHOPPING IS COMING.
10. HEALTH: FARMERS AND BEES IN MEXICO BEAT BIOTECH GIANT - FOR NOW.
12. FINAL WORDS; A 5D TRIBUTE TO ROBIN WILLIAMS.
Dr. Arlan Andrews, Sr., is the founder of SIGMA, the Science Fiction Think Tank, which works with the US government and non-profit organizations to provide the unique futurism of science fiction writers for those who need it most. See the SIGMA website at SigmaForum(dot)org for more details, and a membership list of outstanding talents.
Arlan began his technical career working as a missile tracking telescope operator at White Sands Missile Range, where he also honed a lifelong interest in unusual phenomena by exploring the enchantment and mysteries of New Mexico while attending college. He worked for AT&T Bell Laboratories on the antiballistic missile program, spent time in China, was appointed as a Fellow in the White House Science Office, and co-founded both a Virtual Reality software company and a biotech equipment company.
All of these groundbreaking activities originated in his fascination with the future and the unknown. He expresses that wonderment by writing both fact and fiction, science and speculation.
We have been massively deceived about what is really going on and who is really in charge.
On Today's show we will be interviewing Jamie Lee.
Jamie started my career on Wall St. in 1985 on the NYSE. For the next seven years Jamie was an Institutional Sales Trader for Robertson, Stephens Investment Bank in San Francisco. They were focused on new start up companies in and around Silicon Valley in the technology, biotech, communications and retail industry's.
Thereafter Jamie founded my own firm, JWL Investments, where Jamie managed mostly friends and family accounts until 2005 when Jamie decided to get out of the banking business. Jamie then moved to the North country of Northern California in Mendocino County with my family to become self-reliant and self-sufficient, as possible and grow our own healthy food as well as become active in a smaller community where much needed change was more possible.
Please go to "The United States is a Private Corporation Not a Public Government" http://www.wakingtimes.com/2014/07/04/independence-day-corporation-united-states-america/ for more details.
Join host, Craig H. Lipset, Head of Clinical Innovation, R&D, Pfizer lead a discussion on what it really means to partner with patients in clinical trials.
Jeri Burtchell, Founder, Partners in Research
Regina Holliday, Artist and Medical Advocate
For more information on Jeri's new launch, visit: Healthivibe.com and for Regina walking gallary, google Regina Holliday, walking gallary.
For more information on the topic of Patients as Partners, visit www.theconferenceforum.org. The Conference Forum presented a program in March 2014 fully dedicated to understanding the journey a patient takes in clinical trials. Also take a look at Disruptive Innovations to Advance Clinical Trials scheduled for September 11-12, 2014 in Boston. This event addresses significant innovation to help improve a patients experience in a clinical trial.
Many nations in the world have become prey to the agribusiness industry as it engulfs more and more crop-lands around the globe. Developing countries in Africa, South America, and Asia, are ripe for the picking, but how far will the push for profit and power go when it comes to the natural development of these vulnerable lands? As the corporate players of biotech and chemical agribusiness work to secure even bigger markets for themselves, what will be the ultimate impact to developing countries, and ultimately, to the rest of us?
Join us today for Women Leading the Way Radio as Deanna Potter, your host of Sassy Sales & Biz Development, interviews Bonnie Kapiloff, Biotech/Pharmaceutical Quality Compliance Consultant for BRK Consulting.
Bonnie will share with us her experience, techniques, and philosophy on how she mastered the world of Quality Compliance as she climbed the corporate ladder and cultivated relationships amongst the day-to-day struggles. She will reveal her learning’s, her experience with leaders in the organization, and what it takes to “sell” your idea to others around you in order to get your objective achieved when battling the picture that others may have painted of you or your department.
From Banking to Finance to Real Estate Development - these are examples of hard-core industries for which women have fought there way to the top. And one may argue that the world of biotech and pharmaceutical development may be amongst the most competitive and cutthroat around. At the end of the day, what does it take to compete for market share or “career” share in the corporate world without having to be seen as the wicked witch of the boardroom? Do image issues really exist? And if so, how do we breakthrough to an even playing field?
In Clinical Air episode # 8, host Craig Lipset, Head of Clinical Innovation, R&D, Pfizer hosts a show discussing investigators as partners in clinical research. Guests include:
Christine Pierre, President, Society of Clinical Research
Jacalyn Kent, Director, Clinical Development Information & Optimization, Eli Lilly
Key topics include:
Misunderstandings around Remote Based Monitoring
Training and communication challenges for remote site managers
What are the real cost savings around RBM...are we just shifting costs?
Real time data and how this should affect sites and payments
Reducing burdens to the sites
Investigator turn over rate, making sites sustainable